Bare Sky Marketing — Healthcare Content WritingIntellia Therapeutics Success In Gene Therapy Leaps AheadNew partnership with Regeneron yields promising resultsJul 6, 2021
Dan SferaCholesterol ChaserFDA approves Regeneron’s Evkeeza for cholesterol treatmentFeb 17, 2021Feb 17, 2021
InHelyxbyAdam JameelTreatment for Ebola and Implications for COVID-19By Harrison YorkNov 26, 2020Nov 26, 2020
Bare Sky Marketing — Healthcare Content WritingREGENERON SEEKING EARLY USE AUTHORIZATION FOR COVID-19 ANTIBODY THERAPYAnother potential treatment option for SARS-CoV-2Oct 29, 2020Oct 29, 2020
Bare Sky Marketing — Healthcare Content WritingIntellia Therapeutics Success In Gene Therapy Leaps AheadNew partnership with Regeneron yields promising resultsJul 6, 2021
Bare Sky Marketing — Healthcare Content WritingREGENERON SEEKING EARLY USE AUTHORIZATION FOR COVID-19 ANTIBODY THERAPYAnother potential treatment option for SARS-CoV-2Oct 29, 2020
Eclectic ScienceRegeneron’s COVID-19 Treatment Doesn’t Use Human Fetal CellsI’ve seen a few memes floating around using the inflammatory language of abortion to inflame certain religious elements. Trying to…Oct 7, 20201
InDataDrivenInvestorbyDaniel G. JenningsIs Regeneron (NASDAQ: REGN) making money? — Market Mad HouseFate gave Regeneron (NASDAQ: REGN) an unexpected boost when doctors treated the president with one of its drugs.Oct 6, 2020
